<div class="raw-html-embed"> Newsletteraktion: Abonnieren Sie jetzt unseren Newsletter und sichern Sie sich bis zum 8. August 2025 10% Rabatt auf Ihre Onlinebestellungen. <a href="/newsletter">Infos und Anmeldung.</a></div>

NL_Doormat: Hintergrundfarbe des Newsletter Banners unten in der Doormat. Mit # eingeben z.B. #1405BE

NL_Doormat: Verlinkung zur Newsletter Seite

Über uns

À propos de nous

Zahlung und Lieferung

Paiement et livraison

Nachhaltigkeit

Durabilité

Open Access

Datenschutz

Protection des données

Karriere

Carrière

Impressum

Mentions légales

LEXIA

LEXIA Arbeitsrecht

Was ist LEXIA?

C'est quoi LEXIA ?

LEXIA Familienrecht

Zeitschriften

Revues

recht

Pflegerecht

ZBJV

forumpoenale

ZStrR

Anwaltsrevue

Revue de l'avocat

RSAS

FamPra.ch

ASYL

Life Science Recht

BlAR

Sachbuch

Livres spécialisés

LOKI

Semaphor

Fokusthemen

Focus

Thema

Recht studieren

Arbeitsrecht

Droit du travail

Studium

Études

Familienrecht

Droit de la famille

Sozialversicherungsrecht

Droit des assurances sociales

Strafrecht

Droit pénal

Publikationen

Publications

Literatur

Onlinemodule LEXIA

Modules en ligne LEXIA

Bücher

Livres

Buchreihen

Collections

Datenbanken

recht.ch

Studienliteratur

Littérature pour les études

Services

Dienstleistungen für

Corporate Books

Publishing Lösungen

Aktuelles

Geschäftskunden

Professionnels

Corporate Publishing

Content solutions

Buchhandlungen

Librairies

Veranstaltungen

Événements

Presse

Dozierende

Enseignants

Studierende

Étudiants

Inserierende

Annonceurs

Newsletter

Blog

Autorinnen/Autoren

Auteurs

Unsere Schreibenden

Hilfe

Unsere Autorinnen und Autoren

Liste

Autorenlounge

Espace des auteurs

Bei uns publizieren

Publier chez nous

Autorenstimmen

Témoignages

Verlag

Éditions

Themen

Mehr wissen

Mitarbeitende

Collaborateurs

Geschichte

Histoire

Vision und Mission

Vision et mission

Unser Magazin

Notre magazine

Unternehmenskultur

Culture d'entreprise

Partner

Partenaires

Kontakt

Contact

Shop

Schweizer Recht

Ausländisches Recht

Über unseren Shop

Neuerscheinungen

Nouveautés

Sortiment und Funktionen

Assortiment et recherche

Vorankündigungen

À paraître

Nach Rechtsgebiet

Par domaine juridique

Kommentare

Commentaires

Ploran E: Sensation and Perception

Sensation and Perception

The Brain, In Theory

How do we combat racism in a world determined to tell us it doesn't exist? To hold the line against racism, we need to know it when we see it. And as the dominant racial group in our society, White people must take up the charge. The problem is that White people haven't been socialised to detect racial bias in the way people of colour do. Racism is more than using racial slurs or overt, hateful speech, and it's more than unintentional slights; it's about an entire system that upholds Whiteness as the preferred standard. Fortunately, detecting it is a skill that can be learned. The Bias Gap is a re-education, call to action and practical guide, full of research-backed strategies including how to: · cultivate a growth mindset about bias · unlearn colourblindness and practice colour consciousness · talk to kids about race and racism - and bring others along for the journey At a time when diversity, equity and inclusion (DEI) is under coordinated attack, The Bias Gap is the essential toolkit for anyone who believes we all have a role to play in creating a more equitable world. Evelyn R. Carter, PhD, is a social psychologist and DEI expert, who has applied cutting-edge bias detection practices in a vast array of industries ranging from higher education to financial services, from technology to retail and professional sports, and at organisations like American Express, Burberry, Nike and Uber. Dr Carter's work has been featured in The Atlantic, Harvard Business Review and more.

How to Detect, Interrupt and Unlearn Bias in Everyday Life

Was That Racist?

Handbook of Clinical Neurology

The evolution of neuroimmunotherapies with the concurrent progress in autoimmune neurology will introduce the book, followed by an update on "non-targeted" therapies highlighting the value of immunosuppressants, plasmapheresis, IVIg or hematopoietic bone marrow transplantation and their mode of action in autoimmune neurology. The new agents in each of these categories, along with biomarkers for therapeutic monitoring and the application of reliable scales in assessing response, will be covered. Chapters will discuss how neuroimmunotherapies work when key molecules and pathways associated with CNS or PNS tissue damage are targeted or inhibited. The volume will describe the approved agents targeting: 1) T-cell intracellular signaling pathways and molecules associated with antigen presentation; 2) B cells, B-cell trophic factors, and autoantibodies; 3) Fc receptor modulation; 4) complement; and 5) cytokines, cell adhesion and transmigration molecules. Didactic schemes and illustrations on how these drugs work in autoimmune neurological diseases will be provided in each chapter. The second part of the book will discuss the latest therapeutics for each major autoimmune neurological disease, aimed to provide a reliable, comprehensive and up-to-date source of information useful for clinical practice and education. Didactic and practical algorithms, a step-by step approach on how best to apply the most suitable therapies for a given state of the disease or proceed to escalation therapies will be provided. Treatment controversies and uncertainties will be authoritatively emphasized by scholars in each field. A chapter addressing potential immunotherapeutic approaches, now on the pipeline or on early trials, as future means of treating some neurodegenerative diseases will be included. Another chapter will cover the new and popular-although controversial -concept of treating autoimmune pain. The book discusses practical therapies with¿traditional immunosuppressants, steroids and IVIg. It describes targeted therapies with monoclonal antibodies or fusion proteins against B cells , T cells, complement, and FcRn, discussing what happens when key factors related to neurological autoimmunity are inhibited. The book provides a "how- to- do" approach for each of the major autoimmune diseases with algorithms and escalation therapies. Dedicated chapters will cover current therapies on encephalitis, NMOSD, Multiple sclerosis , autoimmune neuropathies, myopathies, neuromuscular junction disorders and neuroexcitability disorders like stiff person syndrome. The book is aimed for practitioners and academicians as a reliable and comprehensive source for applying neuroimmunotherapies and understanding their mechanisms.

Immunotherapies for Neurologic Diseases: Volume 214

Picador Collection

The Mind's Eye

Learn the science behind why stories can have so much power in The Stories of Your Life, from bestselling author and psychology professor Ben Ambridge.

How Storytelling Explains Who We Are

The Stories of Your Life

A revolutionary new paradigm for understanding addictionWhy do people with addiction use drugs self-destructively? Why don't they quit out of self-concern? Why does the rat in the experiment, alone in a cage, press the lever again and again for cocaine-to the point of death? In this pathbreaking book, Hanna Pickard proposes a new paradigm for understanding the puzzle of addiction. For too long, our thinking has been hostage to a false dichotomy: either addiction is a brain disease, or it is a moral failing. Pickard argues that it is neither, and that both models stifle addiction research and fail people who need help. Drawing on her expertise as an academic philosopher and her clinical work in a therapeutic community, Pickard explores the meaning of drugs for people with addiction and the diverse factors that keep them using despite the costs. People use drugs to cope with suffering-but also to self-harm, or even to die. Some identify as "addicts," while others are in denial or struggle with cravings and self-control. Social, cultural, and economic circumstances are crucial to explaining addiction-but brain pathology may also matter. By integrating addiction science with philosophy, clinical practice, and the psychology and voices of people with addiction themselves, Pickard shows why there is no one-size-fits-all theory or ethics of addiction. The result is a heterogeneous and humanistic paradigm for understanding and treating addiction, and a fresh way of thinking about responsibility, blame, and relationships with people who use drugs.

A Philosophy of Addiction

What Would You Do Alone in a Cage with Nothing but Cocaine?

How Languages Reveal Differences in How We Think

A Myriad of Tongues

Current Tools and Their Capabilities

Brain Imaging Essentials

Ancient Wisdom for a Better Night’s Rest

How to Sleep Like a Caveman

Classical Continuum

Metaphors and Metonyms that Construct the Homeric Odyssey

Time, Tripods, Textiles, and Trees

Neurobiology of Metaplasticity

Principles, Algorithms, and Applications of the Free Energy Principle for Engineers

Fundamentals of Active Inference

Sensation and Perception

Bibliografische Angaben

Schlagworte

Bibliografische Angaben

Schlagworte

Weitere Titel zum Thema